Exane Derivatives’s Meta Platforms (Facebook) META Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100
Closed -$1.33M 958
2020
Q4
$1.33M Buy
+100
New +$27.4K 0.39% 52
2015
Q2
Sell
-500
Closed -$75.3K 542
2015
Q1
$75.3K Sell
500
-500
-50% -$39.2K 0.01% 286
2014
Q4
$10K Buy
+1,000
New +$76.4K ﹤0.01% 412

Other funds holding META

Exane Derivatives's META Position: Q2 2022 in Review

Exane Derivatives increased its Meta Platforms (Facebook) (META) stake by 20% in Q2 2022, buying an estimated $274K and bringing the position to 8,517 shares worth $1.37M. The position accounts for 0.79% of the portfolio, ranked #28.

Exane Derivatives first reported a position in META in Q4 2014 and has held it in 23 quarters since. The position peaked at $20.4M in Q4 2015. 3,074 funds tracked by Wall St. Rank hold META as of Q2 2022.

  • Exane Derivatives held 8,517 shares of Meta Platforms (Facebook) worth $1.37M as of Q2 2022.
  • Exane Derivatives bought 1,420 Meta Platforms (Facebook) shares in Q2 2022, an estimated $274K.
  • Meta Platforms (Facebook) made up 0.79% of Exane Derivatives's portfolio in Q2 2022, its #28 holding.
  • Exane Derivatives first reported a position in Meta Platforms (Facebook) in Q4 2014 and has held it in 23 quarters since.
  • Exane Derivatives's Meta Platforms (Facebook) position peaked at $20.4M in Q4 2015.
  • 3,074 funds tracked by Wall St. Rank held Meta Platforms (Facebook) as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.